Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
7,300.00    605.00 (9.04%)
Bid:
7,695.00
Ask:
5,695.00
Spread: -2,000.00 (-25.991%)
Market Cap: £4.94b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Vulcanic Acquisition Agreement Executed

25 Jul 2022 07:30

RNS Number : 5266T
Spirax-Sarco Engineering PLC
25 July 2022
 

 

News Release

 

25th July 2022

 

Acquisition of Vulcanic - Definitive Agreement Executed

Spirax-Sarco Engineering plc, the thermal energy management and niche pumping specialist, announces that it has now signed a binding definitive agreement to acquire the Vulcanic Group of Companies (Vulcanic) from Qualium, a French private equity company, for a consideration of €261.7 million on a cash and debt free basis, subject to customary closing adjustments.

 

Signature of this definitive agreement follows the conclusion of exclusive negotiations announced on 4th July 2022.

 

As previously stated, the transaction will require regulatory approvals in France and Germany. These regulatory approvals and completion are expected during the third quarter of the year.

 

 

 

Enquiries:

Nimesh Patel, Chief Financial Officer

Andrew Guthrie, Head of Investor Relations

Tel: +44 01242 535035

 

 

 

About Spirax‐Sarco Engineering plc

Spirax‐Sarco Engineering plc is a thermal energy management and niche pumping specialist. It comprises three world‐leading Businesses: Steam Specialties, for the control and management of steam; Electric Thermal Solutions, for advanced electrical process heating and temperature management solutions; and Watson-Marlow, for peristaltic pumping and associated fluid path technologies. The Steam Specialties and Electric Thermal Solutions Businesses provide a broad range of fluid control and electrical process heating products, engineered packages, site services and systems expertise for a diverse range of industrial and institutional customers. Both Businesses help their end users to improve production efficiency, meet their environmental sustainability targets, improve product quality and enhance the safety of their operations. Watson‐Marlow provides solutions for a wide variety of demanding fluid path applications with highly accurate, controllable and virtually maintenance-free pumps and associated technologies.

 

The Group is headquartered in Cheltenham, UK, has strategically located manufacturing plants around the world and employs more than 8,700 people, including almost 2,000 direct sales and service engineers. The Company's shares have been listed on the London Stock Exchange since 1959 (symbol: SPX) and it is a constituent of the FTSE 100 and the FTSE4Good indices.

 

 

Further information can be found at www.spiraxsarcoengineering.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQGZGZNLDZGZZM
Date   Source Headline
8th Apr 20259:34 amRNSDirector/PDMR Shareholding
8th Apr 20259:32 amRNSNotice of AGM
27th Mar 20254:06 pmRNSDirector/PDMR Shareholding
27th Mar 20254:06 pmRNSDirector/PDMR Shareholding
19th Mar 202511:43 amRNSHolding(s) in Company
12th Mar 20257:00 amRNSDividend Declaration
11th Mar 20257:00 amRNS2024 Full Year Results
10th Mar 20251:42 pmRNSDirector/PDMR Shareholding
10th Feb 20252:23 pmRNSDirector/PDMR Shareholding
31st Jan 20259:00 amRNSBoard Appointment
14th Jan 20253:00 pmRNSDirector/PDMR Shareholding
2nd Jan 20257:00 amRNSBoard Chair Succession
11th Dec 20241:53 pmRNSDirector/PDMR Shareholding
27th Nov 20244:18 pmRNSDirector/PDMR Shareholding
15th Nov 20241:19 pmRNSDirector/PDMR Shareholding
14th Nov 20247:00 amRNSTrading Update
16th Oct 20248:48 amRNSHolding(s) in Company
11th Oct 20241:50 pmRNSDirector/PDMR Shareholding
11th Oct 20247:00 amRNSDirector/PDMR Shareholding
10th Oct 20243:29 pmRNSHolding(s) in Company
3rd Oct 20247:00 amRNSCapital Markets Event
18th Sep 20249:47 amRNSHolding(s) in Company
16th Sep 202410:12 amRNSHolding(s) in Company
13th Sep 202410:57 amRNSHolding(s) in Company
12th Aug 202410:44 amRNSDirector/PDMR Shareholding
8th Aug 20247:00 amRNS2024 Half Year Results
1st Jul 20247:05 amRNSConfirmation of CFO Start Date
5th Jun 20243:46 pmRNSChange of Name
29th May 20248:45 amRNSBoard Succession
15th May 20244:56 pmRNSResult of AGM
15th May 20247:00 amRNSAGM Trading Statement
10th Apr 20244:44 pmRNSDirector/PDMR Shareholding
26th Mar 20249:33 amRNSDirector/PDMR Shareholding
20th Mar 202410:00 amRNSDirector/PDMR Shareholding
18th Mar 20242:34 pmRNSHolding(s) in Company
7th Mar 20247:00 amRNS2023 Full Year Results
22nd Feb 20247:00 amRNSSpirax-Sarco Engineering rebrands as Spirax Group
1st Feb 20243:38 pmRNSChange of Director Details
30th Jan 202411:15 amRNSFuture Board Change
17th Jan 20247:00 amRNSLeadership Succession
18th Dec 20237:00 amRNSChief Financial Officer Appointment
21st Nov 20239:15 amRNSDirector/PDMR Shareholding
20th Nov 20237:00 amRNSDirector/PDMR Shareholding
20th Nov 20237:00 amRNSShare Purchases
16th Nov 20237:00 amRNSTrading Update
11th Oct 20238:40 amRNSDirector/PDMR Shareholding
25th Aug 20239:30 amRNSHolding(s) in Company
25th Aug 20238:30 amRNSHolding(s) in Company
10th Aug 20237:00 amRNS2023 Half Year Results
8th Aug 20237:00 amRNSGroup Chief Executive Succession

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.